Catalyst Wire Dossier Catalyst Wire Dossier

Cemiplimab

cemiplimab · Regeneron
Drug timelines are a Plus or Pro feature.

79 regulatory and trial events tracked for Cemiplimab, covering 2016-11-07 to 2026-06-18. Get the full timeline:

Most recent: Clinical Trial Results: A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma [Phase 1, Phase 2]

See pricing